A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients.

Bai, Wen Dong; Liu, Jun Yu; Li, Miao; Yang, Xi; Wang, Yu Lan; Wang, Guang Jun; Li, Shi Chao

Bai, Wen Dong; Liu, Jun Yu; Li, Miao; Yang, Xi; Wang, Yu Lan; Wang, Guang Jun; Li, Shi Chao.

Afiliação

Bai WD; Department of Hematology, General Hospital of Xinjiang Military Command, Urumqi, Xinjiang, China.
Liu JY; These authors contributed equally to this work.
Li M; Department of Gastroenterology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510060, China.
Yang X; These authors contributed equally to this work.
Wang YL; School of Rehabilitation Medicine, Xinjiang Medical University, Urumqi, Xinjiang, China.
Wang GJ; These authors contributed equally to this work.
Li SC; Department of Medical Service, General Hospital of Xinjiang Military Command, Urumqi, Xinjiang, China.

World J Oncol ; 13(5): 299-310, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36406193

Palavras-chave

Biomarker; Cuproptosis; DLAT; Hepatocellular carcinoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: World J Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google